4.5 Review

Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

The emerging roles of circRNAs in cancer and oncology

Lasse S. Kristensen et al.

Summary: Circular RNAs (circRNAs) are a novel class of primarily non-coding RNAs with increasingly recognized roles in cancer development and progression through diverse mechanisms of action. In this review, the authors summarize the current understanding of circRNA biogenesis, regulation, physiological functions and pathophysiological roles in cancer. They also discuss the clinical potential of circRNAs as biomarkers, therapeutic agents and drug targets in oncology, as well as the research controversies, technical issues, and biological knowledge gaps that need to be addressed.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Review Biotechnology & Applied Microbiology

Targeting cancer metabolism in the era of precision oncology

Zachary E. Stine et al.

Summary: In the past century, there have been significant advancements in targeting cancer metabolism, but progress in the past decade has been limited. Some metabolism-based drugs for cancer have been successfully developed and are in clinical trials. However, consideration of the metabolism of non-cancer cells is crucial for successful treatment of cancer.

NATURE REVIEWS DRUG DISCOVERY (2022)

Editorial Material Genetics & Heredity

Histone lactylation: epigenetic mark of glycolytic switch

Xiaofeng Dai et al.

Summary: Y histone lactylation and acetylation compete for epigenetic modification and mark the levels of lactates and acetyl-CoA. The choice between lactate and acetyl-CoA generation from glycolysis determines cell fate towards malignancy. Controlling the glycolytic switch marked by lactylation may offer novel therapeutic opportunities against cancer.

TRENDS IN GENETICS (2022)

Review Oncology

Hallmarks of Cancer: New Dimensions

Douglas Hanahan

Summary: The concept of the hallmarks of cancer is a tool for simplifying the complexity of cancer phenotypes and genotypes into basic principles. This article proposes phenotypic plasticity and disrupted differentiation as distinct hallmark capabilities, and discusses nonmutational epigenetic reprogramming and polymorphic microbiomes as enabling characteristics. Additionally, the importance of senescent cells in the tumor microenvironment is highlighted. The integrative concept of the hallmarks of cancer helps in understanding the mechanisms of cancer development and applying that knowledge to cancer medicine.

CANCER DISCOVERY (2022)

Article Oncology

Mutant IDH Inhibits IFNγ-TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma

Meng-Ju Wu et al.

Summary: Mutant IDH1 (mIDH1) supports cholangiocarcinoma tumor maintenance through immunoevasion and inactivation of TET2, and pharmacologic mIDH1 inhibition stimulates immune response and TET2-dependent induction of IFNγ response genes, which can be enhanced by CTLA4 blockade.

CANCER DISCOVERY (2022)

Review Oncology

Spatial omics: Navigating to the golden era of cancer research

Yingcheng Wu et al.

Summary: This article reviews the technological progress of spatial omics in capturing the spatial architecture of tumour microenvironment (TME). It discusses the potential clinical translations of spatial omics in precision oncology and proposes the application of spatial ecological principles to cancer biology. Spatial omics plays a crucial role in decoding the TME ecosystem and may revolutionize current molecular medical research.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

A plant immune protein enables broad antitumor response by rescuing microRNA deficiency

Ye Qi et al.

Summary: Aberrant accumulation of microRNA isoforms is found in many human primary tumors. By controlling the expression of RDR1 and repairing defective microRNA structures, cancer cell proliferation can be inhibited, showing broad antitumor effects.
Article Oncology

TET3 promotes AML growth and epigenetically regulates glucose metabolism and leukemic stem cell associated pathways

Alex Jose Pulikkottil et al.

Summary: The overexpression of TET3 in AML patients plays an important role in regulating glucose metabolism in AML cells. Depletion of TET3 makes AML cells highly sensitive to the blockade of glycolysis and STAT5 signaling pathways, providing a potential therapeutic approach for targeting AML.

LEUKEMIA (2022)

Review Oncology

Oncometabolites drive tumorigenesis by enhancing protein acylation: from chromosomal remodelling to nonhistone modification

Yidian Fu et al.

Summary: Metabolites, intermediate products of cellular metabolism, can modify proteins to regulate gene expression and intracellular signaling pathways. This review focuses on nine novel lysine acylations beyond acetylation, summarizing their characteristics, functions, and potential applications in tumor control and therapy.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Medicine, General & Internal

Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia

Pau Montesinos et al.

Summary: This study demonstrated that the combination therapy of oral ivosidenib and azacitidine showed better event-free survival and longer overall survival in patients with newly diagnosed IDH1-mutated acute myeloid leukemia.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Medicine, General & Internal

Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor

Tengrui Zhang et al.

Summary: We investigated the underlying mechanisms behind the inadequate anti-cancer activity of the EZH2 inhibitor GSK126 in solid tumors. Our study revealed that although the proliferative phenotype did not show significant differences, there were profound changes in the transcriptome and metabolome upon GSK126 treatment. Dysregulated lipid metabolism, characterized by increased lipid synthesis and abundance of unsaturated fatty acids, was found to blunt the sensitivity of cancer cells to GSK126. Combining GSK126 with an SCD1 inhibitor attenuated cancer proliferation and increased sensitivity to GSK126 by suppressing fatty acid desaturation.

EBIOMEDICINE (2022)

Article Oncology

Novel insights into RB1 mutation

Yiran Yao et al.

Summary: This review focuses on the mechanism underlying RB1 mutation during oncogenesis, as well as potential clinical strategies for treating RB1-mutated cancers. The unsolved problems and prospects of RB1 mutation are also discussed.

CANCER LETTERS (2022)

Article Oncology

Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia

Vladimir Ivanov et al.

Summary: Venetoclax combined with azacitidine shows promising results in improving overall survival and achieving durable remissions in AML patients ineligible for intensive chemotherapy. The VIALE-M study aims to evaluate the safety and efficacy of venetoclax plus oral azacitidine as maintenance therapy for patients in complete remission with incomplete blood count recovery.

FUTURE ONCOLOGY (2022)

Article Hematology

Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose- escalation, dose-expansion, phase 1-2 study

Alexandre Bazinet et al.

Summary: The combination of azacitidine and venetoclax shows promising results in terms of safety and activity in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia.

LANCET HAEMATOLOGY (2022)

Article Endocrinology & Metabolism

Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics

Qi Liu et al.

Summary: The non-oxidative pentose phosphate pathway (PPP) regulates the function of T-reg cells to prevent autoimmune diseases. Deficiency of transketolase (TKT), an enzyme of non-oxidative PPP, impairs the function of T-reg cells and leads to autoimmune diseases. The changes in metabolism and epigenetic processes caused by TKT deficiency result in the dysfunction of T-reg cells and the development of autoimmune diseases.

NATURE METABOLISM (2022)

Review Biochemistry & Molecular Biology

Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine

Chen Xue et al.

Summary: Cancer is a major disease that poses a threat to human life and health worldwide. This review explores the role of RNA modifications in cancer progression and provides a detailed summary of the deposition and functions of common RNA modifications in coding and noncoding RNAs. It also discusses the expression, function, and underlying molecular mechanism of these modifications in cancer, as well as the potential of small-molecule inhibitors.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Biochemical Research Methods

Systematic Proteome and Lysine Succinylome Analysis Reveals Enhanced Cell Migration by Hyposuccinylation in Esophageal Squamous Cell Carcinoma

Zhenchang Guo et al.

Summary: Esophageal squamous cell carcinoma (ESCC) is a aggressive malignancy with poor therapeutic outcomes. The alterations in proteins and posttranslational modifications (PTMs) leading to the pathogenesis of ESCC remain unclear. This study identifies abnormal protein and PTM pathways, including significantly downregulated lysine succinylation sites in cancer cells. Additionally, the restoration of succinylation inhibits cancer cell migration and negatively regulates histone methylation to promote cancer migration.

MOLECULAR & CELLULAR PROTEOMICS (2021)

Review Biology

Non-coding RNAs: the new central dogma of cancer biology

Phei Er Saw et al.

Summary: Non-coding RNAs play crucial roles in cellular regulation and have been identified as key players in various networks, with both oncogenic and tumor suppressive functions in major cancers. Further understanding of ncRNAs could lead to more personalized therapeutic strategies.

SCIENCE CHINA-LIFE SCIENCES (2021)

Article Medicine, Research & Experimental

ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis

Hao Yu et al.

Summary: In bladder cancer, downregulation of ALKBH5 is associated with worse prognosis, and knockdown of ALKBH5 promotes cell proliferation, migration, and invasion while decreasing sensitivity to cisplatin chemotherapy. ALKBH5 inhibits bladder cancer progression and sensitizes cells to cisplatin through regulation of the m6A-dependent casein kinase 2 (CK2)α-mediated glycolysis pathway.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Review Biochemistry & Molecular Biology

Non-coding RNAs and potential therapeutic targeting in cancer

Shusuke Toden et al.

Summary: Recent advances have highlighted the importance of non-coding RNAs, particularly microRNAs, in cancer pathogenesis. These ncRNAs have shown potential for therapeutic development in cancer, with early data from pre-clinical studies demonstrating promising results in human trials. While miRNAs have been extensively studied, there is ongoing research to uncover the molecular mechanisms and therapeutic targets of other lesser studied ncRNAs in cancer treatment.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Article Oncology

Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism

Ling-Yan Cai et al.

Summary: This study demonstrates p300/CBP as a critical epigenetic regulator of glycolysis-related metabolic enzymes in HCC and identifies the p300/CBP inhibitor B029-2 as a potential therapeutic strategy in this disease.

CANCER RESEARCH (2021)

Article Oncology

Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell Carcinoma

Guangxi Sun et al.

Summary: This study conducted integrated genomic, epigenomic, and molecular analyses on 25 untreated primary FH-deficient RCCs, revealing low somatic mutation burden, frequent somatic copy-number alterations, and a CpG sites island methylator phenotype in these tumors. Clinical data showed that patients treated with immune checkpoint blockade-based therapy had significantly longer progression-free survival compared to those receiving antiangiogenic monotherapy.

CLINICAL CANCER RESEARCH (2021)

Review Biochemistry & Molecular Biology

m6A RNA methylation: from mechanisms to therapeutic potential

P. Cody He et al.

Summary: m(6)A, the most prevalent mRNA modification, regulates gene expression by influencing mRNA metabolism in various physiological and pathophysiological processes. It plays a multifaceted role in mRNA decay, translation, and transcription, highlighting its crucial importance in post-transcriptional gene expression regulation.

EMBO JOURNAL (2021)

Article Biochemistry & Molecular Biology

Histone acetyltransferase 1 is a succinyltransferase for histones and non-histones and promotes tumorigenesis

Guang Yang et al.

Summary: Lysine succinylation is an evolutionarily conserved and widespread post-translational modification. HAT1 modulates lysine succinylation on various proteins in cancer cells, playing critical roles in tumor progression.

EMBO REPORTS (2021)

Article Gastroenterology & Hepatology

Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer

William M. Grady et al.

Summary: Colorectal cancer, liver cancer, stomach cancer, pancreatic cancer, and esophageal cancer are leading causes of cancer-related deaths worldwide. Gastrointestinal cancers are characterized by genomic and epigenomic DNA alterations. Epigenetic alterations have emerged as robust biomarkers for cancer screening and surveillance.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer

Jie Hong et al.

Summary: The study revealed a positive correlation between Fusobacterium nucleatum and high glucose metabolism in patients with colorectal cancer (CRC), suggesting a potential role of gut microbiota in CRC development. Mechanistically, Fusobacterium nucleatum activated the lncRNA ENO1-IT1 pathway to regulate CRC cell glucose metabolism and biological functions. Targeting the ENO1 pathway may have therapeutic implications for CRC patients with elevated Fusobacterium nucleatum levels.
Article Cell Biology

HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α

Nanmu Yang et al.

Summary: HBXIP drives metabolic reprogramming in HCC cells via METTL3-mediated m6A modification of HIF-1 alpha.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Oncology

Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

Courtney D. DiNardo et al.

Summary: The combination therapy of ivosidenib and azacitidine showed promising results in treating IDH1-mutant acute myeloid leukemia, with a well-tolerated safety profile and deep, durable responses observed in patients, especially those achieving complete remission and mIDH1 mutation clearance in bone marrow cells.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer progression via the WNT2/β-catenin pathway

Jiacheng Cao et al.

Summary: The study found that circLMO7 can promote the proliferation, migration, and invasion of gastric cancer cells by acting as a sponge for miR-30a-3p to affect the WNT2/beta-Catenin pathway. Animal experiments also showed that circLMO7 could promote gastric cancer growth and metastasis in vivo. Furthermore, circLMO7 can also impact the glutamine metabolism of gastric cancer cells through the WNT2/beta-Catenin pathway to enhance its malignant biological function.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Biochemistry & Molecular Biology

R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis

Ying Qing et al.

Summary: R-2-hydroxyglutarate (R-2HG) inhibits aerobic glycolysis in leukemia cells by targeting RNA modification, highlighting the therapeutic potential of targeting cancer epitranscriptomics and metabolism. This study reveals previously unrecognized effects of R-2HG on leukemia cells, providing insights into novel treatments for cancer.

MOLECULAR CELL (2021)

Review Cell Biology

Gene regulation by long non-coding RNAs and its biological functions

Luisa Statello et al.

Summary: Recent studies have shed new light on the biogenesis and functions of long non-coding RNAs (lncRNAs), showcasing their diverse roles in gene regulation and signaling pathways, particularly in the contexts of neuronal disorders, immune responses, and cancer. The discovery of unique biogenesis pathways and subcellular localizations of lncRNAs has opened up potential therapeutic avenues for targeting lncRNAs in various biological and pathophysiological conditions.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer

Jing Han et al.

Summary: Trastuzumab resistance poses a significant challenge in treating HER-2-positive breast cancer. This study reveals that MSC-induced upregulation of AGAP2-AS1 promotes stemness and trastuzumab resistance through activating FAO. AGAP2-AS1 may serve as a promising predictive biomarker and therapeutic target for these patients.

ONCOGENE (2021)

Article Multidisciplinary Sciences

EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma

Runping Fang et al.

Summary: In this study, it was revealed that YTHDF2 overexpression is associated with poor prognosis in glioma patients due to EGFR-induced protein stabilization, leading to reduced cholesterol homeostasis and promoting GBM tumorigenesis through an RNA m6A methylation dependent mechanism.

NATURE COMMUNICATIONS (2021)

Article Oncology

Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death

Vicente Fresquet et al.

Summary: Epigenetic therapies induce viral mimicry in cancer cells, reshaping mitochondrial metabolism and driving caspase-independent tumor cell death, leading to increased sensitivity to BCL2 inhibitor drugs.

CANCER DISCOVERY (2021)

Letter Hematology

Decitabine and venetoclax for IDH1/2-mutated acute myeloid leukemia

Sangeetha Venugopal et al.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Article Oncology

HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness

Lei Bi et al.

Summary: The study reveals that HDAC11 is highly expressed in HCC and its loss can reduce hepatocellular tumorigenesis and prolong survival. Loss of HDAC11 promotes histone acetylation in the promoter of LKB1 gene, activating the AMPK signaling pathway to inhibit glycolysis and suppress cancer stemness and HCC progression.

CANCER RESEARCH (2021)

Article Oncology

Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial

Courtney D. DiNardo et al.

Summary: The study evaluated the safety and activity of enasidenib plus azacitidine in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia, showing that the combination therapy significantly improved overall response rates compared to azacitidine monotherapy, which may lead to improved outcomes for these patients.

LANCET ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Succinylation of H3K122 destabilizes nucleosomes and enhances transcription

Lara Zorro Shahidian et al.

Summary: The study reveals the important role of H3K122 succinylation in chromatin function and transcription, demonstrating its ability to stimulate transcription and its enrichment on promoters of active genes. The identification of proteins involved in succinylation and desuccinylation of H3K122 sheds light on the mechanisms underlying transcriptional regulation by H3K122succ. Additionally, single molecule FRET assays show a direct effect of H3K122succ on nucleosome stability, highlighting the significance of histone succinylation in modulating chromatin dynamics.

EMBO REPORTS (2021)

Article Genetics & Heredity

Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states

Ronan Chaligne et al.

Summary: This study reveals the key switches for state transitions in diffuse gliomas, recapitulating neurodevelopmental trajectories and highlighting dysregulated epigenetic mechanisms underlying gliomagenesis. The work also demonstrates heritability of malignant cell states and differences in cell state architectures in different types of glioma. Additionally, the study links tumor cell transcriptional states to epigenetics and shows the heritability and importance of these states for tumor plasticity.

NATURE GENETICS (2021)

Article Cell Biology

Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p/HIF-1α negative feedback loop in melanoma

Yan Liu et al.

Summary: LINC00518 is a long noncoding RNA that is highly expressed in various cancers, including cutaneous malignant melanoma (CMM), and plays a role in promoting cancer progression. In CMM, LINC00518 induces radioresistance by regulating the glycolysis pathway through a negative feedback loop involving miR-33a-3p and hypoxia-inducible factor 1 alpha (HIF-1 alpha). Knockdown of LINC00518 expression sensitizes CMM cells to radiotherapy, suggesting a potential strategy to improve treatment outcomes.

CELL DEATH & DISEASE (2021)

Article Medicine, Research & Experimental

circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression

Yingkuan Liang et al.

Summary: The aberrant expression of circRNAs plays a role in cancer progression through interactions with RNA-binding proteins (RBPs). A novel circRNA, circDCUN1D4, has been identified to be involved in the metastasis and glycolysis of lung adenocarcinoma (LUAD) by facilitating interactions between HuR and TXNIP proteins. It acts as a scaffold to enhance stability and transportation of TXNIP mRNA, ultimately suppressing metastasis and glycolysis of lung cancer cells in a TXNIP-dependent manner. The downregulated expression of circDCUN1D4 in lymph node metastatic tissues serves as an independent risk factor for the overall survival of LUAD patients.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Review Biochemistry & Molecular Biology

Understanding the Function of Mammalian Sirtuins and Protein Lysine Acylation

Miao Wang et al.

Summary: Protein lysine acetylation is a key posttranslational modification that regulates biological processes. In addition to acetylation, other acyl-lysine modifications such as succinylation, crotonylation, and long-chain fatty acylation also play important biological roles. The study of sirtuins has provided valuable information about lysine acylation functions and their regulation is crucial for cell response to signals and stresses.

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 90, 2021 (2021)

Article Oncology

USP48 Is Upregulated by Mettl14 to Attenuate Hepatocellular Carcinoma via Regulating SIRT6 Stabilization

Lutao Du et al.

Summary: The study reveals that USP48 binds and stabilizes SIRT6 through K48-linked deubiquitination, inhibiting metabolic reprogramming and tumorigenesis in HCC. Additionally, Mettl14-induced m(6)A modification regulates USP48 and contributes to HCC by maintaining USP48 mRNA stability, highlighting the importance of metabolic activities in HCC treatment.

CANCER RESEARCH (2021)

Article Cell Biology

Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance

Yi Liu et al.

Summary: Research has identified the m(6)A demethylase FTO as a key regulator in tumors, impacting immune surveillance through glycolytic metabolism regulation. Knockdown of FTO impairs tumor cell glycolytic activity, restores CD8(+) T cell function, and inhibits tumor growth. Additionally, the development of the small-molecule compound Dac51 can block FTO-mediated immune evasion and synergize with checkpoint blockade for improved tumor control.

CELL METABOLISM (2021)

Article Multidisciplinary Sciences

Fatty acid oxidation is a druggable gateway regulating cellular plasticity for driving metastasis in breast cancer

Ser Yue Loo et al.

Summary: Cell state transitions are controlled by lipid metabolism reprogramming. Retinoids promote MET and inhibit tumorigenesis in basal-like breast cancer. Fatty acid oxidation impacts epigenetic control and cell state transitions.

SCIENCE ADVANCES (2021)

Article Oncology

Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p/GOT1 axis in pancreatic cancer

Xiaoxiao Zhou et al.

Summary: The study revealed that circ-MBOAT2 regulates the development of pancreatic cancer and glutamine metabolism through the miR-433-3p/GOT1 axis, suggesting a potential therapeutic target for inhibiting tumor formation.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Biochemistry & Molecular Biology

mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis

Elodie Villa et al.

Summary: mTORC1 regulates m(6)A RNA modification by controlling MAT2A and WTAP levels to promote protein synthesis and cell growth.

MOLECULAR CELL (2021)

Article Multidisciplinary Sciences

Cell-programmed nutrient partitioning in the tumour microenvironment

Bradley Reinfeld et al.

Summary: The study found that in the tumor microenvironment, different cell types have varying abilities to access and consume glucose and glutamine, with nutrient partitioning being programmed in a cell-intrinsic manner through mTORC1 signaling and the expression of genes related to glucose and glutamine metabolism.

NATURE (2021)

Article Cell Biology

WNT/β-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis

Xueying Yang et al.

Summary: FTO plays a critical role in cancer development by removing m(6)A modifications from genes. Downregulation of FTO expression in lung adenocarcinoma patients is associated with poor survival. Mechanistically, Wnt signaling induces EZH2 binding to beta-catenin, inhibiting FTO expression and promoting m(6)A modifications on specific genes like MYC to enhance tumor cell glycolysis and growth.

CELL DEATH & DISEASE (2021)

Article Multidisciplinary Sciences

LncRNA GIRGL drives CAPRIN1-mediated phase separation to suppress glutaminase-1 translation under glutamine deprivation

Ruijie Wang et al.

Summary: GIRGL is a long noncoding RNA induced during glutamine starvation, associated with translational suppression of GLS1. Cellular GIRGL levels are balanced by transactivation by c-JUN and negative stability regulation by HuR/Ago2. Elevated GIRGL levels drive formation of a complex between CAPRIN1 dimers and GLS1 mRNA, promoting liquid-liquid phase separation of CAPRIN1 and stress granule formation.

SCIENCE ADVANCES (2021)

Review Oncology

N6-methyladenosine Steers RNA Metabolism and Regulation in Cancer

Shenghua Dong et al.

Summary: m(6)A, a key RNA modification, controls gene expression and impacts physiological/pathological processes like cancer. Dysregulation of m(6)A regulators is linked to cancer initiation, progression, and drug resistance. Potential clinical implications include using m(6)A methylation as prognostic biomarkers and drug targets for cancer therapy.

CANCER COMMUNICATIONS (2021)

Article Oncology

The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer

Jing-Zi Wang et al.

Summary: This study demonstrated that ALYREF stabilizes PKM2 mRNA and binds to its m5C sites in bladder cancer, promoting cell proliferation. High expressions of PKM2 and ALYREF predict poor prognosis in bladder cancer patients. Additionally, HIF-1alpha indirectly upregulates PKM2 expression by activating ALYREF, suggesting a promising therapeutic target for bladder cancer.

CANCER COMMUNICATIONS (2021)

Review Cell Biology

Histone succinylation and its function on the nucleosome

Jiayi Liu et al.

Summary: Lysine succinylation is a newly identified histone post-translational modification that influences nucleosomal structure, chromatin dynamics, gene expression, and several diseases. Studies on lysine succinylation of histones are ongoing, highlighting its potential as a target for disease treatment in the future.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Oncology

Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression

Hongtao Liu et al.

Summary: Recent studies have shown that SLC2A1-AS1 may play a critical role in tumor development and progression in esophageal cancer patients by regulating glycolysis, and the SLC2A1-AS1/miR-378a-3p/Glut1 regulatory axis could be a novel therapeutic target for metabolic remodeling in esophageal cancer patients.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Oncology

被撤回的出版物: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 (Retracted article. See vol. 42, 2023)

Guizhi Jia et al.

Summary: This study identified the upregulation of LNCAROD in HCC patients, predicting a poor prognosis, and revealed that LNCAROD promotes HCC progression through PKM2-mediated glycolysis enhancement. The molecular mechanism involves the interaction with different factors and sponging miR-145-5p to maintain PKM2 levels, especially under hypoxic conditions, providing a potential diagnostic marker and therapeutic target for HCC patients.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Biochemistry & Molecular Biology

CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner

Xin Liu et al.

Summary: The study identified an intron-derived circRNA, circMYH9, significantly upregulated in colorectal cancer tissues. CircMYH9 promotes colorectal cancer proliferation through modulating serine/glycine metabolism and redox homeostasis in a p53-dependent manner.

MOLECULAR CANCER (2021)

Article Biochemistry & Molecular Biology

Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2

Yongzhen Mo et al.

Summary: Our study revealed that a novel circRNA, circRNF13, plays a crucial role in NPC development through the circRNF13-SUMO2-GLUT1 axis. CircRNF13 inhibits NPC proliferation and metastasis by activating SUMO2 and regulating the AMPK-mTOR pathway to inhibit glycolysis. This research provides a theoretical basis for further understanding NPC pathogenesis and developing targeted therapies.

MOLECULAR CANCER (2021)

Article Cell Biology

Novel circular RNA circSLIT2 facilitates the aerobic glycolysis of pancreatic ductal adenocarcinoma via miR-510-5p/c-Myc/LDHA axis

Hua Guan et al.

Summary: The novel circRNA circSLIT2 is significantly upregulated in PDAC and is associated with unfavorable prognosis. Functional experiments show that circSLIT2 promotes aerobic glycolysis and proliferation of PDAC cells by acting as a miRNA sponge to regulate the miR-510-5p/c-Myc axis. This circSLIT2/miR-510-5p/c-Myc axis participates in the aerobic glycolysis and carcinogenesis of PDAC, suggesting it may be a promising therapeutic target.

CELL DEATH & DISEASE (2021)

Article Cell Biology

C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1

Baochi Ou et al.

Summary: A novel subset of C5aR1-positive neutrophils inducing breast cancer glycolysis through ERK1/2-WTAP-dependent m6A methylation of ENO1 has been discovered. These neutrophils are associated with tumor growth and poor prognosis in breast cancer patients.

CELL DEATH & DISEASE (2021)

Article Cell Biology

CircC16orf62 promotes hepatocellular carcinoma progression through the miR-138-5p/PTK2/AKT axis

Shuai Zhang et al.

Summary: CircC16orf62 acts as an oncogene in HCC progression, promoting cancer development through the miR-138-5p/PTK2/Akt pathway. It functions as a molecular sponge for miR-138-5p and a competitive endogenous RNA for PTK2, activating the AKT/mTOR pathway.

CELL DEATH & DISEASE (2021)

Article Multidisciplinary Sciences

METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding

Wei Wang et al.

Summary: This study demonstrates that METTL3 downregulates APC by upregulating its m(6)A modification and recruiting YTHDF2 for APC mRNA degradation, leading to enhanced glycolysis and tumor growth in esophageal cancer.

NATURE COMMUNICATIONS (2021)

Article Oncology

Lactate Modulates Cellular Metabolism Through Histone Lactylation-Mediated Gene Expression in Non-Small Cell Lung Cancer

Jun Jiang et al.

Summary: Lactate plays a role in modulating cellular metabolism in non-small cell lung cancer by reducing glucose uptake and glycolysis while maintaining mitochondrial homeostasis. The regulation of gene expression through histone lactylation is involved in this metabolic modulation.

FRONTIERS IN ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

The existence of a nonclassical TCA cycle in the nucleus that wires the metabolic-epigenetic circuitry

Xujun Liu et al.

Summary: This study identified a nonclassical TCA cycle in the nucleus, which is mainly involved in generating and consuming metabolic intermediates while closely linked to chromatin dynamics and transcription regulation.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Oncology

Roles and Regulation of TET Enzymes in Solid Tumors

Julie K. Bray et al.

Summary: TET enzymes play a crucial role in oxidizing 5mC and promoting cytosine demethylation, impacting the carcinogenesis process. This review outlines various aspects of TET regulation and discusses how TET deregulation contributes to a cancer phenotype.

TRENDS IN CANCER (2021)

Article Biotechnology & Applied Microbiology

Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma

Jie Yu et al.

Summary: The study reveals that histone lactylation is increased in tumors, promoting tumorigenesis by facilitating YTHDF2 expression and degradation of m6A-modified PER1 and TP53 mRNA. This provides new therapeutic targets and insights into epigenetic regulation in tumorigenesis.

GENOME BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Risk SNP-induced lncRNA-SLCC1 drives colorectal cancer through activating glycolysis signaling

Tingting Yan et al.

Summary: The study identified a risk SNP-mediated oncogene lncRNA-SLCC1 that promotes colorectal cancer by activating the glycolysis pathway, with its expression levels associated with patient survival.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Oncology

The metabolism of cancer cells during metastasis

Gabriele Bergers et al.

Summary: This review discusses the metabolic rewiring in cancer cells during the metastatic cascade and the distinct metabolic features of primary tumors and metastases. Metastasis is the leading cause of death in most cancer patients, and targeting metastatic seeding and colonization remains a significant challenge. Adjusting metabolism may provide therapeutic opportunities to prevent or reduce metastasis, and targeting the new metabolic traits in established metastases could lead to their eradication.

NATURE REVIEWS CANCER (2021)

Article Biochemistry & Molecular Biology

Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1

Shuyu Zhai et al.

Summary: LINC00261 has been identified as a tumor suppressor in pancreatic cancer, inhibiting cancer progression through various mechanisms including inducing cell cycle arrest and apoptosis. Its expression levels are closely associated with pathological stage and prognosis, revealing its crucial role and regulatory mechanisms in pancreatic cancer.

ONCOGENE (2021)

Review Oncology

New insights into molecules and pathways of cancer metabolism and therapeutic implications

Zhenye Tang et al.

Summary: Cancer cells, characterized by unlimited proliferation, transformation, and migration, acquire molecular materials and energy through unusual metabolic pathways. Various carcinogenic signaling pathways converge to regulate glucose, lipid, and amino acid metabolism in tumor cells. The distinct metabolic signatures of cancer cells indicate that metabolic changes are crucial for the development of tumor cells.

CANCER COMMUNICATIONS (2021)

Article Oncology

Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma

Shuai Wu et al.

Summary: Mutations in components of the SWI/SNF chromatin remodeling complex, such as ARID1A, lead to a dependence on glutamine metabolism. Inactivation of ARID1A upregulates GLS1, increasing glutamine utilization and metabolism to support aspartate synthesis. Pharmacological inhibition of glutaminase with CB-839 alone or in combination with immune checkpoint blockade shows promise as a therapeutic strategy for cancers with SWI/SNF complex alterations, including ARID1A mutations.

NATURE CANCER (2021)

Article Medicine, Research & Experimental

Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma

Chuanjie Zhang et al.

Summary: Low expression of METTL14 in mRCC samples predicts poor prognosis; METTL14 deficiency promotes RCC metastasis via negative regulation of BPTF mRNA stability through m(6)A modification; BPTF inhibitor AU1 shows efficacy in suppressing mRCC.

THERANOSTICS (2021)

Review Biotechnology & Applied Microbiology

Synthetic lethality as an engine for cancer drug target discovery

Alan Huang et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Review Cell Biology

Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer

Marteinn Thor Snaebjornsson et al.

CELL METABOLISM (2020)

Review Cell Biology

AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control

Asier Gonzalez et al.

CELL METABOLISM (2020)

Review Gastroenterology & Hepatology

Epigenetics of colorectal cancer: biomarker and therapeutic potential

Gerhard Jung et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Biochemistry & Molecular Biology

Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma

Kulandaimanuvel Antony Michealraj et al.

Article Multidisciplinary Sciences

N6-methyladenosine regulates glycolysis of cancer cells through PDK4

Zihan Li et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming

Jia Liu et al.

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

m6A-dependent glycolysis enhances colorectal cancer progression

Chaoqin Shen et al.

MOLECULAR CANCER (2020)

Article Cell Biology

Extracellular serine controls epidermal stem cell fate and tumour initiation

Sanjeethan C. Baksh et al.

NATURE CELL BIOLOGY (2020)

Review Biochemical Research Methods

Metabolic regulation of epigenetic remodeling in immune cells

Emily C. Britt et al.

CURRENT OPINION IN BIOTECHNOLOGY (2020)

Article Medicine, Research & Experimental

HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models

Trang Thi Thu Nguyen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Oncology

EZH2: a novel target for cancer treatment

Ran Duan et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Article Multidisciplinary Sciences

Oncometabolites suppress DNA repair by disrupting local chromatin signalling

Parker L. Sulkowski et al.

NATURE (2020)

Article Gastroenterology & Hepatology

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Jesus M. Banales et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Medicine, General & Internal

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

C. D. DiNardo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medicine, General & Internal

Epigenetic Therapies for Cancer

Susan E. Bates

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2

Chunqing Wang et al.

NATURE COMMUNICATIONS (2020)

Review Genetics & Heredity

The evolving metabolic landscape of chromatin biology and epigenetics

Ziwei Dai et al.

NATURE REVIEWS GENETICS (2020)

Article Multidisciplinary Sciences

The m(6)A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor

Yiren Xiao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Biochemistry & Molecular Biology

Circular RNA: metabolism, functions and interactions with proteins

Wei-Yi Zhou et al.

MOLECULAR CANCER (2020)

Review Biochemistry & Molecular Biology

NAD+metabolism: pathophysiologic mechanisms and therapeutic potential

Na Xie et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Oncology

The epigenomics of sarcoma

Benjamin A. Nacev et al.

NATURE REVIEWS CANCER (2020)

Review Oncology

Role of RNA modifications in cancer

Isaia Barbieri et al.

NATURE REVIEWS CANCER (2020)

Article Biochemistry & Molecular Biology

The Landscape of Circular RNA in Cancer

Josh N. Vo et al.

Article Biochemistry & Molecular Biology

The circular RNome of primary breast cancer

Marcel Smid et al.

GENOME RESEARCH (2019)

Review Biochemistry & Molecular Biology

Lactate: A Metabolic Driver in the Tumour Landscape

Luigi Ippolito et al.

TRENDS IN BIOCHEMICAL SCIENCES (2019)

Article Multidisciplinary Sciences

Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts

Mark A. Eckert et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

Methionine is a metabolic dependency of tumor-initiating cells

Zhenxun Wang et al.

NATURE MEDICINE (2019)

Review Biochemistry & Molecular Biology

Past, present, and future of circRNAs

Ines Lucia Patop et al.

EMBO JOURNAL (2019)

Article Biochemistry & Molecular Biology

MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma

Nathanael H. Green et al.

ONCOGENE (2019)

Review Endocrinology & Metabolism

Should we consider subcellular compartmentalization of metabolites, and if so, how do we measure them?

Kathryn E. Wellen et al.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2019)

Article Multidisciplinary Sciences

α-Ketoglutarate links p53 to cell fate during tumour suppression

John P. Morris et al.

NATURE (2019)

Review Genetics & Heredity

The biogenesis, biology and characterization of circular RNAs

Lasse S. Kristensen et al.

NATURE REVIEWS GENETICS (2019)

Review Cell Biology

The diverse roles of DNA methylation in mammalian development and disease

Maxim V. C. Greenberg et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Review Biochemistry & Molecular Biology

The Role of Non-coding RNAs in Oncology

Frank J. Slack et al.

Article Medicine, Research & Experimental

Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression

Huanhuan Li et al.

EMBO MOLECULAR MEDICINE (2019)

Article Multidisciplinary Sciences

Inducing and exploiting vulnerabilities for the treatment of liver cancer

Cun Wang et al.

NATURE (2019)

Article Multidisciplinary Sciences

Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs

William A. Flavahan et al.

NATURE (2019)

Article Multidisciplinary Sciences

Metabolic regulation of gene expression by histone lactylation

Di Zhang et al.

NATURE (2019)

Article Multidisciplinary Sciences

LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc

Jiayin Tang et al.

NATURE COMMUNICATIONS (2019)

Review Biochemistry & Molecular Biology

The DNA methylation landscape in cancer

Ksenia Skvortsova et al.

DNA METHYLATION (2019)

Review Biochemistry & Molecular Biology

The novel roles of circRNAs in human cancer

Qingfeng Shang et al.

MOLECULAR CANCER (2019)

Review Cell Biology

Functions and mechanisms of non-histone protein acetylation

Takeo Narita et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer

Yun Wang et al.

MOLECULAR CANCER (2019)

Article Oncology

Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis

Alessandro Carrer et al.

CANCER DISCOVERY (2019)

Review Biotechnology & Applied Microbiology

Epigenetic modifications of histones in cancer

Zibo Zhao et al.

GENOME BIOLOGY (2019)

Review Genetics & Heredity

The DNA methyltransferase family: a versatile toolkit for epigenetic regulation

Frank Lyko

NATURE REVIEWS GENETICS (2018)

Review Oncology

Glioma epigenetics: From subclassification to novel treatment options

Olga Gusyatiner et al.

SEMINARS IN CANCER BIOLOGY (2018)

Article Biochemistry & Molecular Biology

R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling

Rui Su et al.

Review Biochemistry & Molecular Biology

Novel insights on m6A RNA methylation in tumorigenesis: a double-edged sword

Shaoyun Wang et al.

MOLECULAR CANCER (2018)

Article Biochemistry & Molecular Biology

Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer

Yonathan Lissanu Deribe et al.

NATURE MEDICINE (2018)

Review Genetics & Heredity

Cancer epigenetics: Moving forward

Angela Nebbioso et al.

PLOS GENETICS (2018)

Article Biochemistry & Molecular Biology

Beyond histone acetylation-writing and erasing histone acylations

Shuai Zhao et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)

Review Oncology

Non-coding RNA networks in cancer

Eleni Anastasiadou et al.

NATURE REVIEWS CANCER (2018)

Article Multidisciplinary Sciences

The role of fatty acid β-oxidation in lymphangiogenesis

Brian W. Wong et al.

NATURE (2017)

Article Genetics & Heredity

SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation

Xiaofeng Wang et al.

NATURE GENETICS (2017)

Review Oncology

Cancer metabolism: a therapeutic perspective

Ubaldo E. Martinez-Outschoorn et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Review Genetics & Heredity

From profiles to function in epigenomics

Stefan H. Stricker et al.

NATURE REVIEWS GENETICS (2017)

Review Cell Biology

Metabolic regulation of gene expression through histone acylations

Benjamin R. Sabari et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)

Review Urology & Nephrology

The epigenetic landscape of renal cancer

Mark R. Morris et al.

NATURE REVIEWS NEPHROLOGY (2017)

Article Biochemistry & Molecular Biology

Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy

Xinjian Li et al.

MOLECULAR CELL (2017)

Article Biochemistry & Molecular Biology

Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination

Sharanya Sivanand et al.

MOLECULAR CELL (2017)

Article Multidisciplinary Sciences

KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase

Yugang Wang et al.

NATURE (2017)

Article Biochemistry & Molecular Biology

L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH

Andrew M. Intlekofer et al.

NATURE CHEMICAL BIOLOGY (2017)

Review Biotechnology & Applied Microbiology

Marked for death: targeting epigenetic changes in cancer

Sophia Xiao Pfister et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Review Genetics & Heredity

Synthetic lethality and cancer

Nigel J. O'Neil et al.

NATURE REVIEWS GENETICS (2017)

Review Genetics & Heredity

TET-mediated active DNA demethylation: mechanism, function and beyond

Xiaoji Wu et al.

NATURE REVIEWS GENETICS (2017)

Review Cell Biology

Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes

Cedric R. Clapier et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)

Article Biochemistry & Molecular Biology

Metabolic inhibitors accentuate the anti-tumoral effect of HDAC5 inhibition

E. Hendrick et al.

ONCOGENE (2017)

Article Multidisciplinary Sciences

Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC

Kiyotoshi Satoh et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway

Xin Gu et al.

SCIENCE (2017)

Review Multidisciplinary Sciences

Epigenetic plasticity and the hallmarks of cancer

William A. Flavahan et al.

SCIENCE (2017)

Review Multidisciplinary Sciences

The cancer epigenome: Concepts, challenges, and therapeutic opportunities

Mark A. Dawson

SCIENCE (2017)

Article Biochemistry & Molecular Biology

LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism

Xin Zheng et al.

EMBO JOURNAL (2017)

Letter Oncology

IDH Mutation, Competitive Inhibition of FTO, and RNA Methylation

Sara M. Elkashef et al.

CANCER CELL (2017)

Review Biochemistry & Molecular Biology

Understanding the Intersections between Metabolism and Cancer Biology

Matthew G. Vander Heiden et al.

Review Cell Biology

One-Carbon Metabolism in Health and Disease

Gregory S. Ducker et al.

CELL METABOLISM (2017)

Article Multidisciplinary Sciences

Insulator dysfunction and oncogene activation in IDH mutant gliomas

William A. Flavahan et al.

NATURE (2016)

Review Cell Biology

The Emerging Hallmarks of Cancer Metabolism

Natalya N. Pavlova et al.

CELL METABOLISM (2016)

Review Cell Biology

Role of TET enzymes in DNA methylation, development, and cancer

Kasper Dindler Rasmussen et al.

GENES & DEVELOPMENT (2016)

Article Biochemistry & Molecular Biology

Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation through De Novo ATP Synthesis in Cancer Cells

Oliver D. K. Maddocks et al.

MOLECULAR CELL (2016)

Article Biochemistry & Molecular Biology

Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2

Roxana S. Redis et al.

MOLECULAR CELL (2016)

Article Multidisciplinary Sciences

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition

Marco Sciacovelli et al.

NATURE (2016)

Article Multidisciplinary Sciences

LKB1 loss links serine metabolism to DNA methylation and tumorigenesis

Filippos Kottakis et al.

NATURE (2016)

Review Genetics & Heredity

A network-biology perspective of microRNA function and dysfunction in cancer

Cameron P. Bracken et al.

NATURE REVIEWS GENETICS (2016)

Article Medicine, General & Internal

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

W. Marston Linehan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Biochemistry & Molecular Biology

Circular RNA profile in gliomas revealed by identification tool UROBORUS

Xiaofeng Song et al.

NUCLEIC ACIDS RESEARCH (2016)

Review Genetics & Heredity

Lateral Thinking: How Histone Modifications Regulate Gene Expression

Moyra Lawrence et al.

TRENDS IN GENETICS (2016)

Article Cell Biology

Histone Modifications and Cancer

James E. Audia et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)

Correction Multidisciplinary Sciences

A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect (vol 5, 3608, 2014)

Paula Lopez-Serra et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia

Xue Gao et al.

NATURE COMMUNICATIONS (2016)

Article Cell Biology

ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch

Steven Zhao et al.

CELL REPORTS (2016)

Review Oncology

From Krebs to clinic: glutamine metabolism to cancer therapy

Brian J. Altman et al.

NATURE REVIEWS CANCER (2016)

Review Oncology

The emerging roles of microRNAs in cancer metabolism

Brian Chan et al.

CANCER LETTERS (2015)

Article Cell Biology

Hypoxia Induces Production of L-2-Hydroxyglutarate

Andrew M. Intlekofer et al.

CELL METABOLISM (2015)

Review Cell Biology

Acetyl Coenzyme A: A Central Metabolite and Second Messenger

Federico Pietrocola et al.

CELL METABOLISM (2015)

Article Cell Biology

Acetyl-CoA and the regulation of metabolism: mechanisms and consequences

Lei Shi et al.

CURRENT OPINION IN CELL BIOLOGY (2015)

Review Cell Biology

Metabolic pathways promoting cancer cell survival and growth

Lindsey K. Boroughs et al.

NATURE CELL BIOLOGY (2015)

Article Medical Laboratory Technology

RNA epigenetics

Nian Liu et al.

TRANSLATIONAL RESEARCH (2015)

Article Biochemistry & Molecular Biology

EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination

L. Gomez-Maldonado et al.

ONCOGENE (2015)

Article Biochemistry & Molecular Biology

Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases

Tomoyuki Mashimo et al.

Article Biochemistry & Molecular Biology

Acetate Dependence of Tumors

Sarah A. Comerford et al.

Article Biochemistry & Molecular Biology

Identification of small ORFs in vertebrates using ribosome footprinting and evolutionary conservation

Ariel A. Bazzini et al.

EMBO JOURNAL (2014)

Article Biochemistry & Molecular Biology

Reciprocal Regulation of HIF-1 alpha and LincRNA-p21 Modulates the Warburg Effect

Fan Yang et al.

MOLECULAR CELL (2014)

Article Oncology

Lactate dehydrogenase A silencing in IDH mutant gliomas

Charles Chesnelong et al.

NEURO-ONCOLOGY (2014)

Article Multidisciplinary Sciences

A long noncoding RNA connects c-Myc to tumor metabolism

Chiu-Lien Hung et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Review Biochemistry & Molecular Biology

The pentose phosphate pathway and cancer

Krushna C. Patra et al.

TRENDS IN BIOCHEMICAL SCIENCES (2014)

Article Cell Biology

Writers and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition

Ronen Marmorstein et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)

Article Cell Biology

Erasers of Histone Acetylation: The Histone Deacetylase Enzymes

Edward Seto et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)

Article Cell Biology

DNA Methylation in Mammals

En Li et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)

Review Cell Biology

Cellular Fatty Acid Metabolism and Cancer

Erin Currie et al.

CELL METABOLISM (2013)

Article Cell Biology

Induction of sarcomas by mutant IDH2

Chao Lu et al.

GENES & DEVELOPMENT (2013)

Review Medicine, Research & Experimental

Glutamine and cancer: cell biology, physiology, and clinical opportunities

Christopher T. Hensley et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Medicine, Research & Experimental

Oncometabolites: linking altered metabolism with cancer

Ming Yang et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Multidisciplinary Sciences

Circular RNAs are a large class of animal RNAs with regulatory potency

Sebastian Memczak et al.

NATURE (2013)

Article Biochemistry & Molecular Biology

NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink

Olesya A. Ulanovskaya et al.

NATURE CHEMICAL BIOLOGY (2013)

Article Multidisciplinary Sciences

(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible

Julie-Aurore Losman et al.

SCIENCE (2013)

Review Endocrinology & Metabolism

miRNAs link metabolic reprogramming to oncogenesis

Maria Hatziapostolou et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)

Article Multidisciplinary Sciences

Tumour angiogenesis regulation by the miR-200 family

Chad V. Pecot et al.

NATURE COMMUNICATIONS (2013)

Review Oncology

Serine, glycine and one-carbon units: cancer metabolism in full circle

Jason W. Locasale

NATURE REVIEWS CANCER (2013)

Editorial Material Biochemistry & Molecular Biology

SnapShot: Histone Lysine Methylase Complexes

Man Mohan et al.

Review Biochemistry & Molecular Biology

Cancer Epigenetics: From Mechanism to Therapy

Mark A. Dawson et al.

Article Biochemistry & Molecular Biology

The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism

Carlos Sebastian et al.

Article Biochemistry & Molecular Biology

Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism

Haoqiang Ying et al.

Article Multidisciplinary Sciences

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

Sevin Turcan et al.

NATURE (2012)

Review Genetics & Heredity

Histone methylation: a dynamic mark in health, disease and inheritance

Eric L. Greer et al.

NATURE REVIEWS GENETICS (2012)

Review Physiology

S-ADENOSYLMETHIONINE IN LIVER HEALTH, INJURY, AND CANCER

Shelly C. Lu et al.

PHYSIOLOGICAL REVIEWS (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Biochemistry & Molecular Biology

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

Rasheduzzaman Chowdhury et al.

EMBO REPORTS (2011)

Article Multidisciplinary Sciences

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Ryan D. Morin et al.

NATURE (2011)

Article Multidisciplinary Sciences

Initial genome sequencing and analysis of multiple myeloma

Michael A. Chapman et al.

NATURE (2011)

Review Biotechnology & Applied Microbiology

Harnessing synthetic lethal interactions in anticancer drug discovery

Denise A. Chan et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Review Oncology

A decade of exploring the cancer epigenome - biological and translational implications

Stephen B. Baylin et al.

NATURE REVIEWS CANCER (2011)

Article Biochemistry & Molecular Biology

The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α

Lei Zhong et al.

Article Biochemistry & Molecular Biology

RNA epigenetics?

Chuan He

NATURE CHEMICAL BIOLOGY (2010)

Review Genetics & Heredity

The widespread regulation of microRNA biogenesis, function and decay

Jacek Krol et al.

NATURE REVIEWS GENETICS (2010)

Review Biochemistry & Molecular Biology

The Biology of Chromatin Remodeling Complexes

Cedric R. Clapier et al.

ANNUAL REVIEW OF BIOCHEMISTRY (2009)

Article Biochemistry & Molecular Biology

Enzymes in the NAD+ Salvage Pathway Regulate SIRT1 Activity at Target Gene Promoters

Tong Zhang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Multidisciplinary Sciences

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Lenny Dang et al.

NATURE (2009)

Review Genetics & Heredity

Long non-coding RNAs: insights into functions

Tim R. Mercer et al.

NATURE REVIEWS GENETICS (2009)

Review Cell Biology

Chromatin remodelling beyond transcription: the INO80 and SWR1 complexes

Ashby J. Morrison et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)

Article Multidisciplinary Sciences

ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation

Kathryn E. Wellen et al.

SCIENCE (2009)

Review Biochemistry & Molecular Biology

The human Mi-2/NuRD complex and gene regulation

S. A. Denslow et al.

ONCOGENE (2007)

Review Endocrinology & Metabolism

ISWI chromatin remodeling in ovarian somatic and germ cells:: revenge of the NURFs

David Pepin et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)

Review Biotechnology & Applied Microbiology

INO80 subfamily of chromatin remodeling complexes

Yunhe Bao et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2007)

Article Biotechnology & Applied Microbiology

The Chd family of chromatin remodelers

Concetta G. A. Marfella et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2007)

Review Biochemistry & Molecular Biology

Dynamic regulation of histone lysine methylation by demethylases

Yang Shi et al.

MOLECULAR CELL (2007)

Review Cell Biology

The multiple faces of caveolae

Robert G. Parton et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)

Article Multidisciplinary Sciences

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

H Farmer et al.

NATURE (2005)

Review Genetics & Heredity

Micrornas: Small RNAs with a big role in gene regulation

L He et al.

NATURE REVIEWS GENETICS (2004)

Article Biochemistry & Molecular Biology

Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer

E Ballestar et al.

EMBO JOURNAL (2003)